This inventor holds 6 USPTO granted patents and 9 published patent applications and 5 EPO patents. Top assignees: Agios Pharmaceuticals, Inc., Other. Active years: 2014-2026.
Company Filing History:
5 out of 99 
1 out of 834,411 Years Active: 2014-2026
Title: Inventor Shengfang Jin: Pioneering Innovations in Cell Proliferation Disorders
Introduction
Shengfang Jin, an accomplished inventor based in Newton, MA, has made significant contributions to the field of medical diagnostics and treatment, particularly in relation to cell proliferation-related disorders. With a total of five patents to his name, he is recognized for his innovative approaches and scientific advancements.
Latest Patents
Shengfang Jin's recent patents focus on the diagnosis and treatment of disorders associated with mutant IDH enzymes, specifically concerning the neoactivity of 2HG. His first notable patent, "Methods for Diagnosing IDH-Mutant Cell Proliferation Disorders," outlines effective methodologies to diagnose subjects exhibiting proliferation-related disorders linked to these mutant enzymes. The second patent, "Methods and Compositions for Cell-Proliferation-Related Disorders," details new methods for the treatment and evaluation of subjects with neoactive mutants, showcasing his commitment to addressing complex health issues.
Career Highlights
Throughout his career, Shengfang Jin has played a crucial role at Agios Pharmaceuticals, Inc., where he has utilized his expertise in developing groundbreaking therapies. His work has not only advanced the company’s research initiatives but has also contributed to the broader understanding of cell proliferation disorders.
Collaborations
Jin has collaborated with various professionals in the field, including notable coworkers such as Stefan Gross and Shin-San Michael Su. These partnerships have been instrumental in fostering innovative solutions and advancing research in the realm of cell proliferation.
Conclusion
Shengfang Jin stands out as a notable inventor whose work addresses significant medical challenges associated with cell proliferation-related disorders. His patents and collaborative efforts demonstrate a strong commitment to innovation in the biomedical sector, impacting the diagnosis and treatment of complex conditions. As research continues to evolve, the contributions of inventors like Jin are vital in shaping the future of healthcare and medical technology.